Menu
Recruiting NCT07635446

Effects of Laura Mitchell's and Benson Relaxation Technique On Anxiety, Sleep Quality and Fatigue Among COPD Patients

No phase Interventional COPD

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Laura Mitchell's Physiological Relaxation Technique., Benson Relaxation.
Who it may be relevant to
Registry conditions: COPD. Basic parameters: 40 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterized by persistent respiratory symptoms and airflow limitation. Patients with COPD often experience not only physical symptoms like breathlessness and fatigue but also psychological issues such as anxiety and poor sleep quality, which further compromise their quality of life. Non-pharmacological interventions, especially relaxation techniques, have shown promise in improving psychological well-being and physiological outcomes in COPD patients. Among these, Laura Mitchell's relaxation technique and Benson's relaxation response have gained attention for their simplicity and effectiveness. The primary objective of this study is to assess and compare the effects of Laura Mitchell's relaxation technique and Benson's relaxation technique on anxiety, sleep quality, and fatigue levels in patients diagnosed with moderate to severe COPD. By evaluating these parameters, the study aims to determine which method provides greater benefits in managing psychological and physical symptoms associated with COPD. The study will use a randomized experimental design. Participants will be randomly assigned into two groups: Group A will receive Laura Mitchell's relaxation training, and Group B will receive Benson's technique. Both interventions will be practiced daily for 15-20 minutes over a 6-weeks period. Baseline and post-intervention (week 6) data will be collected. Outcome measures will include anxiety (GAD-7), fatigue (FSS) and sleep quality (PSQI). Data will be analyzed using paired and independent t-tests to assess within-group and between-group differences, with significance set at p \< 0.05. The data will be analyzed using SPSS v 25.

Interventions

  • Behavioral Laura Mitchell's Physiological Relaxation Technique.
    This technique involves awareness of postural alignment, controlled muscular tension-release, and slow rhythmic breathing. Participants will then be instructed to perform the technique daily for 15-20 minutes over a period of 6 weeks at home. Each participant will maintain a daily logbook recording the time, duration, and any feedback regarding their practice.
  • Behavioral Benson Relaxation
    The session will include instruction on deep breathing, mental repetition of a calming word or phrase (e.g., "relax" or "one"), and passive redirection of attention away from distracting thoughts. Participants will then practice the technique daily for 15-20 minutes for 6 weeks in a quiet environment. Each participant will also maintain a daily practice logbook.

Primary outcome measures

  • Change in Anxiety Severity Assessed by the Generalized Anxiety Disorder-7 [Time frame: 6 week]
  • Pitts burg Sleep Quality index [Time frame: 6 week]
Secondary outcome measures (1)
  • Change in Fatigue Severity Assessed by the Fatigue Severity Scale [Time frame: 6 week]

Eligibility criteria

Inclusion criteria

\- Gender: Male and Female

  • Age: 40 to 60 years
  • Patients diagnosed with COPD
  • Willing to participate

Exclusion criteria

  • Patients with Exacerbations within past 4 weeks
  • Cardiac Diseases (Acute MI, Congestive Heart Failure)
  • Neuromuscular Disorder
  • Recent lung diseases
  • Hemodynamic instability
  • Respiratory failure

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Gulab Devi Hospital — Lahore

Identifiers

NCT: NCT07635446 · REC/RCR & AHS/25/0308

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗